Risk of myocardial infarction or vascular death after first ischemic stroke - The northern Manhattan study

被引:105
作者
Dhamoon, Mandip S.
Tai, Wanling
Boden-Albala, Bernadette
Rundek, Tanja
Paik, Myunghee C.
Sacco, Ralph L.
Elkind, Mitchell S. V.
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA
[2] Columbia Univ, Dept Biostat, Joseph P Mailman Sch Publ Hlth, New York, NY USA
[3] Columbia Univ, Dept Sociomed Sci, Joseph P Mailman Sch Publ Hlth, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY USA
[5] Columbia Univ, Joseph P Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA
关键词
cerebrovascular disease; mortality; prognosis; risk factors; stroke;
D O I
10.1161/STROKEAHA.106.480988
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - In national guidelines, absolute long-term risk of myocardial infarction ( MI) or coronary death determines target low-density lipoprotein levels, but stroke patients are not explicitly addressed. We determined the absolute 5-year risk of cardiovascular outcomes and their predictors after first ischemic stroke in a multiethnic cohort. Methods - A population-based cohort of first ischemic stroke patients >= 40 years old was prospectively followed annually for recurrent stroke, MI and cause-specific mortality. Kaplan-Meier 5-year risks for MI or vascular death ( primary outcome), and other cardiovascular events, were calculated. Univariate and multivariate Cox proportional hazards models were used to calculate hazard ratios and 95% CI for predictors of cardiovascular outcomes. Results - Mean age ( n = 655) was 69.7 +/- 12.7 years; 55.4% of participants were women, and 51.3% Hispanic. The 5-year risk of MI or vascular death was 17.4% ( 95% CI, 14.2% to 20.6%). Independent historical predictors of MI or vascular death were age > 70 years ( hazard ratio 1.62, 1.07 to 2.44), history of coronary artery disease ( hazard ratio 1.76, 1.13 to 2.74), and atrial fibrillation ( hazard ratio 1.76, 1.05 to 2.94). In the lowest risk group, those <= 70 years old without coronary artery disease, 5-year risk of MI or vascular death was 9.7%. Conclusions - The absolute risk of MI or vascular death after ischemic stroke, even in those without high-risk features, approximates levels used by national organizations to designate groups of patients at high risk of vascular events. The comparability of levels of absolute risk among stroke and cardiac patients may have treatment implications.
引用
收藏
页码:1752 / 1758
页数:7
相关论文
共 39 条
[1]   Design of the trial of Org 10172 in acute stroke treatment (TOAST) [J].
Adams, HP ;
Woolson, RF ;
Clarke, WR ;
Davis, PH ;
Bendixen, BH ;
Love, BB ;
Wasek, PA ;
Grimsman, KJ .
CONTROLLED CLINICAL TRIALS, 1997, 18 (04) :358-377
[2]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549
[3]  
Byington RP, 2001, CIRCULATION, V103, P387
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]  
Collins R, 2004, LANCET, V363, P757
[6]   European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts) [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, I ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
ATHEROSCLEROSIS, 2003, 171 (01) :145-155
[7]   LONG-TERM SURVIVAL AFTER 1ST-EVER STROKE - THE OXFORDSHIRE COMMUNITY STROKE PROJECT [J].
DENNIS, MS ;
BURN, JPS ;
SANDERCOCK, PAG ;
BAMFORD, JM ;
WADE, DT ;
WARLOW, CP .
STROKE, 1993, 24 (06) :796-800
[8]   THE ASSOCIATION OF STROKE AND CORONARY HEART-DISEASE - A POPULATION STUDY [J].
DEXTER, DD ;
WHISNANT, JP ;
CONNOLLY, DC ;
OFALLON, WM .
MAYO CLINIC PROCEEDINGS, 1987, 62 (12) :1077-1083
[9]   European stroke prevention study .2. Efficacy and safety data - Introduction [J].
Diener, HC ;
Forbes, C ;
Riekkinen, PJ ;
Sivenius, J ;
Smets, P ;
Lowenthal, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 151 :S1-+
[10]   THE STROKE DATA-BANK - DESIGN, METHODS, AND BASELINE CHARACTERISTICS [J].
FOULKES, MA ;
WOLF, PA ;
PRICE, TR ;
MOHR, JP ;
HIER, DB .
STROKE, 1988, 19 (05) :547-554